Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Feb. 12, 1998

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Positive preclinical results reported for IPL-423

Feb. 10, 1998

Several related series of MMP inhibitors claimed by Bayer

Feb. 9, 1998

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

Phase III results reported for Prosorba

Jan. 30, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...